期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Cancer stem cell-mediated therapeutic resistance in hepatocellular carcinoma
1
作者 Mei-Mei Li Yi-Ti He +3 位作者 jie-kai liang Xin-Yuan Guan Ning-Fang Ma Ming Liu 《Hepatoma Research》 2022年第1期393-414,共22页
Hepatocellular carcinoma(HCC)is a highly heterogeneous malignancy.In the clinic,therapeutic resistance is largely attributed to tumor heterogeneity.Growing evidence indicates that cancer stem cells(CSCs)are the major ... Hepatocellular carcinoma(HCC)is a highly heterogeneous malignancy.In the clinic,therapeutic resistance is largely attributed to tumor heterogeneity.Growing evidence indicates that cancer stem cells(CSCs)are the major source of tumor heterogeneity.Hence,uncovering the resistance mechanisms associated with CSC properties is essential for developing effective therapeutics.CSCs resemble embryonic stem cells.Embryonic developmentrelated genes and signaling pathways are usually abnormally active and function as oncofetal drivers in HCC.Multiple strategies have been applied to identify oncofetal drivers.The mechanisms of CSC resistance could also provide reliable biomarkers to predict treatment failure.Precisely targeting these specific CSC properties may be effective in preventing or annihilating therapy resistance.This review provides an overview of drug resistance mechanisms associated with CSC traits and summarize therapeutic strategies against drug resistance. 展开更多
关键词 Hepatocellular carcinoma HETEROGENEITY cancer stem cell drug resistance precision therapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部